250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical VC (Venture Capital) Funds in Belgium in September 2025

A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Belgium. We rank investors based on the number of investments they made in Medical companies from Belgium. We update this investor list every month.

Top 50 Medical VC (Venture Capital) Funds in Belgium in September 2025

Investor Medical Belgium investments
Meusinvest (Noshaq) 8
Capricorn Partners 5
Newton Biocapital 5
Limburgse Reconversie Maatschappij 5
V-Bio Ventures 4
Qbic Fund 4
PMV 3
Fund+ 3
S.R.I.W. 3
GoBeyond 3
Gemma Frisius Fund 3
WING by Digital Wallonia 3
Mérieux Equity Partners 3
Mérieux Equity Partners 3
White Fund 2
Forbion Capital Partners 2
Inventures SA 2
Be Angels 2
Spinventure 2
BioGeneration Ventures 2
Thuja Capital 2
BAN Vlaanderen 2
Buysse & Partners 2
Sambrinvest 2
Omnes Capital 2
Volta Ventures 2
Flanders Future Techfund 2
Droia Ventures 1
Sofinnova Investments 1
Debiopharm Innovation Fund 1
Hunza Ventures 1
Wellington Partners 1
LeanSquare 1
New Rhein 1
Quest for Growth 1
Limburg Startup 1
Dental Innovation Alliance 1
EQT Life Sciences 1
Earlybird Venture Capital 1
Allegro Investment Fund 1
Ackermans & van Haaren 1
Financière Spin-Off Luxembourgeoise 1
The CoFoundry 1
Sofinnova Partners 1
Investsud 1
SFPI-FPIM 1
CPH Banque 1
Delta Partners 1
HTGF (High-Tech Gruenderfonds) 1
Gimv 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Meusinvest (Noshaq) VC Fund · Liège, Liege, Belgium · 3 investments in the past 12 months
Noshaq offers financial services to help businesses develop.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Funding Round
  • Belgium, France, Germany
Portfolio highlights
  • TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
  • Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
  • Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
Capricorn Partners VC Fund · Leuven, Vlaams-Brabant, Belgium · 3 investments in the past 12 months
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Funding Round, Series B, Series A
  • Belgium, United States, The Netherlands
Portfolio highlights
  • InsectSense — MIMICKING HOW INSECTS SENSE | Biomimetic technology based on the sensing mechanism of insects. A deeptech platform that applies synthetic biology, microfluidics and is powered by machine learning.
  • Minze Health — Digital Urology Starts Here from symptom to solution Home-based digital diagnostics and therapeutics for Male LUTS/BPH and OAB. Shaping the future of urology through meaningful data. Get In Touch Our Mission We're redefining how Male LUTS/BPH and OAB are diagnosed and treated Today's Challenge Lower urinary tract symptoms (LUTS) affect a growing group of patients.
  • Econic Technologies — At Econic, we are pioneering the transformation of CO2 into high-performance materials that shape a better future for all.
Newton Biocapital VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in the past 12 months
Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Series A, Funding Round, Seed
  • Belgium, Japan, France
Portfolio highlights
  • AdipoPharma — AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases.
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
  • Tensegrity Pharma — Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.
Limburgse Reconversie Maatschappij VC Fund · Hasselt, Limburg, Belgium
Oxygen for growth - LRM
Show more
Investment focus
  • Information Technology, Software, Biotechnology
  • Funding Round, Series A, Seed
  • Belgium, United States, The Netherlands
Portfolio highlights
  • Cumul.io — Create powerful dashboards in minutes. Share with your teams, or integrate in your platform. Drive growth in your business today!
  • ADLC — ADLC employs drone technology to deliver logistics services, allowing businesses to implement drone-based solutions without having to manage them in-house. The company is focused on enhancing last-mile delivery in maritime and offshore environments. ADLC now conducts drone delivery services in the Port of Antwerp in collaboration with SGS, atesting and certification company, and works with companies such as BASF. Its drones have reduced delivery times and environmental effect, boosting efficiency sixfold and lowering CO2 emissions by up to 80% for petrochemical sample deliveries.
  • Raw Stadia — Raw Stadia is a sports technology company that specializes in surface player interactions.
V-Bio Ventures VC Fund · Gent, Oost-Vlaanderen, Belgium · 2 investments in the past 12 months
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Seed
  • Belgium, France, United Kingdom
Portfolio highlights
  • Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
  • ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
  • Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
Qbic Fund VC Fund · Belgium, Wisconsin, United States · 2 investments in the past 12 months
The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Seed, Funding Round, Series A
  • Belgium
Portfolio highlights
  • Pleevi — AI powered smart charging to charge fleet more cost-efficient and cleaner on professional sites
  • Weavely — Design forms in Figma - publish with Weavely. We turn your visual ideas into interactive, web-based forms.
  • Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
PMV VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 4 investments in the past 12 months
Do and dare company
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Series A, Seed, Series B
  • Belgium, United States, The Netherlands
Portfolio highlights
  • Nobi — Fall detection for the elderly at your home or in a residential care center with the smart Nobi lamp. Nobi ensures that you can be helped quickly.
  • Apideck — Apideck gives vertical SaaS companies one unified API to launch accounting integrations in weeks. The fastest way for developers to build integrations.
  • Swave Photonics — Swave develops Spatial Computing, Holography, holographic chips, and holograms in the HXR chip to create 3D augmented and virtual reality and HUD Heads Up Displays
Fund+ VC Fund · Leuven, Vlaams-Brabant, Belgium
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • Belgium, United States, Spain
Portfolio highlights
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
S.R.I.W. VC Fund · Liège, Liege, Belgium
The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.
Show more
Investment focus
  • Biotechnology, Health Care, Manufacturing
  • Funding Round, Series A, Series B
  • Belgium, United States, Spain
Portfolio highlights
  • Univercells — We are biotech innovators, rooted in Belgium, driven by one purpose: To transform how biotech drugs are made so everyone, everywhere, can get them.
  • Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
  • Santero Therapeutics — This is the homepage of the website
GoBeyond VC Fund · Zürich, Zurich, Switzerland
GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
Show more
Investment focus
  • Information Technology, Medical, Software
  • Funding Round, Seed, Series A
  • Switzerland, Germany, United Kingdom
Portfolio highlights
  • LEND — LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.
  • AVAtronics — AVA Active Noise Cancellation (ANC) Solution is a breakthrough in Audio Industry. AVA is the first and only TRUE WIDE-BAND ANC in the market capable of selectively cancelling all annoying noises we want to get rid of without compromising the quality of Music or speech.
  • Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
Gemma Frisius Fund VC Fund · Leuven, Vlaams-Brabant, Belgium
Gemma Frisius Fund KU Leuven is a seed capital fund that aims to stimulate the creation and growth of university related spin-off companies.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series B, Series A
  • Belgium, France, United Kingdom
Portfolio highlights
  • Protealis — Sustainable plant proteins for Europe​
  • Tavira Therapeutics — Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.
  • Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
WING by Digital Wallonia VC Fund · Liège, Liege, Belgium
W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).
Show more
Investment focus
  • Software, Health Care, Internet
  • Seed, Convertible Note, Series A
  • Belgium
Portfolio highlights
  • IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
  • MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
  • Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.
Mérieux Equity Partners VC Fund · Lyon, Rhone-Alpes, France · 2 investments in the past 12 months
Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Funding Round, Private Equity
  • France, United States, Belgium
Portfolio highlights
  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
  • CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Mérieux Equity Partners VC Fund · Lyon, Rhone-Alpes, France
Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Private Equity, Funding Round
  • France, Belgium, United Kingdom
Portfolio highlights
  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Prothea Technologies — Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.
  • CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
White Fund VC Fund
For game changers in medtech
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Series A, Series B
  • Belgium
Portfolio highlights
  • Axithra — Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
  • Minze Health — Digital Urology Starts Here from symptom to solution Home-based digital diagnostics and therapeutics for Male LUTS/BPH and OAB. Shaping the future of urology through meaningful data. Get In Touch Our Mission We're redefining how Male LUTS/BPH and OAB are diagnosed and treated Today's Challenge Lower urinary tract symptoms (LUTS) affect a growing group of patients.
  • Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Forbion Capital Partners VC Fund · Naarden, Noord-Holland, The Netherlands · 13 investments in the past 12 months
Impacting the future of medicine.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
  • Eeden — Eeden engages in the manufacture and supply of textiles.
  • Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
Inventures SA VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.
Show more
Investment focus
  • Health Care, Manufacturing, Biotechnology
  • Series A, Seed, Funding Round
  • Belgium, France, United Kingdom
Portfolio highlights
  • BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
  • myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
  • Octave — A sustainable, cost-effective and reliable energy storage system with second-life batteries from electric vehicles.
Be Angels VC Fund · Louvain-la-neuve, Vlaams-Brabant, Belgium
Early stage Entrepreneurs Coaching and FinancingOne of Europe's leading Business Angels Networks. We connect innovative growth companies to equity finance and coaching by experienced angel investors. The network is 250 members strong and has been assisting innovative entrepreneurs to find financing for more than 10 millions Euros in thelast 4 years.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Pre-Seed, Funding Round
  • Belgium, France, Spain
Portfolio highlights
  • Savics — Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.
  • DeftHedge — DeftHedge is an application addressed to business leaders, and CFOs facing volatility of foreign exchange market.
  • NIUM — NIUM is a startup focused on personalized nutrition and gut microbiome research. NIUM created science-based solutions to transform nutrition research and product development.
Spinventure VC Fund · Angleur, Liege, Belgium
Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège. It is headquartered in Angleur, Belgium.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Funding Round
  • Belgium
Portfolio highlights
  • Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
  • Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
  • Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.
BioGeneration Ventures VC Fund · Naarden, Noord-Holland, The Netherlands · 5 investments in the past 12 months
Shaping new life-science ventures.
Show more
Investment focus
  • Biotechnology, Therapeutics, Health Care
  • Series A, Funding Round, Seed
  • The Netherlands, United States, Belgium
Portfolio highlights
  • Citryll — Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and other human diseases. The company offers formation, function, and clearance of NETs downstream of the protein citrullination pathway catalyzed by Peptidylarginine Deiminase (PAD) enzymes that enable doctors to help in the treatment of lupus,vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis.Citryll was established in 2015 and is headquartered in Oss, The Netherlands.
  • Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
  • Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
Thuja Capital VC Fund · Utrecht, Utrecht, The Netherlands
Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Funding Round, Series A, Seed
  • The Netherlands, Belgium, United States
Portfolio highlights
  • Pan Cancer — Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer.
  • Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
  • Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
BAN Vlaanderen VC Fund · Hasselt, Limburg, Belgium
BAN Vlaanderen is the business angel network in Flanders, a value-added platform within which new or growing businesses are brought into contact with informal private investors, called Business Angels. Looking for venture capital This Business Angels bring not only money but also their own know-how, experience and contacts. Are connecting servicesoffered. Both the entrepreneurs and the business angelsBAN Vlaanderen is no investment, it does not own shares or take any investment decisions, nor for its own account or on behalf of the affiliates. Instead, it is a market where supply and demand are brought together. The information on this site is intended to initiate the purpose and operation of BAN Vlaanderen. For more information you can always contact one of our regional offices.BAN Vlaanderen is an association that aims to stimulate the development, support and promotion of entrepreneurship and investment culture in Belgium. Economic growth in Belgium
Show more
Investment focus
  • Health Care, Medical, Apps
  • Funding Round, Seed, Series A
  • Belgium
Portfolio highlights
  • OutKept — Can you be phished? Verhoog je bewustzijn en naleving met volledig geautomatiseerde phishing-simulaties gemaakt door een community van ethische phishers.
  • Pom — POM stands for Peace of Mind. And it's exactly that worry-free feeling that they want their customers to achieve through their invoice management solutions, both for the receiver and the sender.Their goal is to eliminate the senseless time and effort spent because of inefficient systems. And thus freeing up time to do the things that reallymatter.
  • Oncomfort — Oncomfort’s solution for digital sedation is a completely new method for relieving patients’ pain and anxiety before, during and after medical procedures. This revolutionising digital therapy combines clinical hypnotherapy and integrative therapeutic techniques through Virtual Reality.
Buysse & Partners VC Fund · Antwerpen, Antwerpen, Belgium
Buysse and Partners is a private equity investment group based in Antwerpen that offers smart equity, a growth fund, and partnerships.
Show more
Investment focus
  • Software, Cloud Computing, FinTech
  • Series A, Seed, Funding Round
  • Belgium, United Kingdom, The Netherlands
Portfolio highlights
  • Twikit — Deliver unforgettable customer experiences with real time 3D product configurators, linked to your existing order and manufacturing flows.
  • Bluebee — Delivering a streamlined way for users to analyze, explore, and manage large-scale genomics data in the cloud.
  • moonbird — Slow breathing is the easiest way to relieve stress and promote relaxation. Moonbird makes it intuitive and easy to do breathing exercises.
Sambrinvest VC Fund · Gosselies, Hainaut, Belgium · 2 investments in the past 12 months
Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.
Show more
Investment focus
  • Biotechnology, Health Care, Information Technology
  • Seed, Series A, Series B
  • Belgium, France, Spain
Portfolio highlights
  • AdipoPharma — AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases.
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
  • ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
Omnes Capital VC Fund · Paris, Ile-de-France, France · 5 investments in the past 12 months
Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Series A, Funding Round, Series B
  • France, Germany, United States
Portfolio highlights
  • Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
  • VSORA — VSORA provides high performance companion solutions combining AI and signal processing to enable autonomous driving and ADAS
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
Volta Ventures VC Fund · Gent, Oost-Vlaanderen, Belgium · 4 investments in the past 12 months
Volta Ventures is a venture capital firm that offers seed & early stage VC for internet & software companies in the Benelux.The fund’s team, with active support from some 30 business angels, expects to make a substantial impact on every company it invests in by working with the founders and management to identify new markets andcustomers, hire senior talent, provide ongoing guidance and arrange further financing rounds.Volta Ventures has offices in Ghent and Amsterdam.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Funding Round
  • Belgium, The Netherlands, Luxembourg
Portfolio highlights
  • LangWatch — LangWatch is an AI agent testing, LLM evaluation, and LLM observability platform. Test agents with simulated users, prevent regressions, and debug issues.
  • Predikt — Predikt empowers finance leaders to navigate today’s volatile markets with clarity and confidence. By integrating advanced AI, external market data, and internal financial metrics, Predikt transforms forecasting into a strategic advantage.Our pioneering Confidence Intelligence platform:- Provides transparency and automation to reduceforecasting uncertainty. - Enables CFOs to assess risks, identify opportunities, and align teams globally. - Turns data into decisions that foster resilience and drive growth.We understand the challenges finance leaders face: juggling a high-level view with local market complexities. That’s why Predikt is designed to enhance collaboration, challenge assumptions, and provide confidence in every number.Founded by a Swiss-Belgian team in 2023, Predikt is democratizing predictive technology, equipping finance teams to make smarter decisions and thrive amid uncertainty.
  • Videobot — Grow your business with personalised video funnels that engage your audience with human interaction, capture leads, guide your users, enhance customer satisfaction and increase conversion rate.Short videos have already become dominant across social media platforms. Now, this beloved user experience is available on company websites as well. The applications are vast and varied. Discover how it all works by reserving your own presentation slot.
Flanders Future Techfund VC Fund
Flanders Future Techfund operates as an investment firm.
Show more
Investment focus
  • Medical, Semiconductor, Clinical Trials
  • Seed
  • Belgium
Portfolio highlights
  • EDGX — EDGX, founded in 2023 in Ghent, is a Belgian Space Tech company developing high-speed edge computing units for satellites. Its NVIDIA-powered Sterna Computer and SpaceFeather software enable real-time, AI-driven on-orbit data processing for applications in communication, Earth observation, and intelligence.
  • Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
  • Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Droia Ventures VC Fund · Luxembourg, Luxembourg, Luxembourg · 4 investments in the past 12 months
Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. We invest in the most promising life science companies.
Show more
Investment focus
  • Biotechnology, Medical, Therapeutics
  • Series A, Series B, Series C
  • United States, Belgium, The Netherlands
Portfolio highlights
  • Judo Bio — Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new treatments for systemic and renal diseases.
  • Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
  • Alesta Therapeutics — Alesta Therapeutics pioneers innovative small molecule therapies for rare diseases, including hypophosphatasia and Charcot-Marie-Tooth
Sofinnova Investments VC Fund · Menlo Park, California, United States · 3 investments in the past 12 months
Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, France, Switzerland
Portfolio highlights
  • Axonis Therapeutics — AXONIS Therapeutics, Inc. is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders.
  • Avenzo Therapeutics — Developing the next generation of oncology therapies for patients.
  • Seaport Therapeutics — Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
Debiopharm Innovation Fund VC Fund · Lausanne, Vaud, Switzerland
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Seed, Series B
  • Switzerland, United States, France
Portfolio highlights
  • Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
  • OmicsChart — OmicsChart is an oncology data company on a mission to revolutionize precision oncology by building a patient-centred cancer data ecosystem, consolidating scattered data, promoting transparency, and advancing clinical research with machine learning on real-world datasets. Our flagship product PREON is an analytics platform for cancer biologists.
  • MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.
Hunza Ventures VC Fund · Luxembourg, Luxembourg, Luxembourg
Hunza Ventures is a venture capital firm incorporated in 1998 in Luxemburg. The firm has focused its investments on early and mid-stage life sciences and IT companies with outstanding growth prospects.Hunza Ventures has built a large and well-balanced portfolio based on the strong entrepreneurial experience of the fund’s shareholders andmanagers. Since inception, Hunza Ventures has backed 20 companies in Belgium, Israel, USA and Singapore.Hunza Ventures has raised two funds:Hunza Ventures raised €15 million. The fund made 14 venture investments and is fully invested. A series of companies have successfully been divested.Hunza Ventures II raised €6.25 million in October 2008. This fund is actively investing and is currently raising additional capital.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Funding Round
  • Belgium, United States
Portfolio highlights
  • ITeos Therapeutics — iTeos Therapeutics is pioneering the discovery and development of highly differentiated immuno-oncology therapeutics for cancer patients.
  • Formac Pharmaceuticals — Formac is a spin-off company from the University of Leuven, Belgium (K.U.Leuven), from which it has obtained the exclusive and worldwide rights to develop and commercialise ordered mesoporous silica materials for the delivery of poorly soluble API's. The company was incorporated on 3 October 2007 and is privately owned. The main shareholdersof Formac are K.U.Leuven, Allegro Investment Fund, Hunza Ventures, Gemma Frisius Fonds K.U.Leuven, Vinnof PMV and Life Sciences Research Partners VZW (formerly D. Collen Foundation).Since its incorporation Formac has signed more than 40 feasibility agreements with Tier 1 Pharma companies and SMEs in the field of human and veterinary medicine. To date, Formac is the only company that demonstrated the clinical relevancy of the silica based technology in a clinical setting.
Wellington Partners VC Fund · Munich, Bayern, Germany · 4 investments in the past 12 months
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Funding Round
  • Germany, United States, United Kingdom
Portfolio highlights
  • Hilo — Founded in Switzerland in May 2018 out of a passion to turn insights into action in the fight against hypertension, Aktiia’s groundbreaking medical technology provides people and their physicians comprehensive insights into blood pressure patterns that will inform the diagnosis and management of hypertension. Now available in the United Kingdom,Aktiia has received its CE Mark as a Class IIa medical device - signifying that the device has been assessed to meet high safety, health and environmental protection requirements in Europe. To learn more, visit Aktiia.com.
  • HepaRegeniX — HepaRegeniX is developing drugs for treating acute and chronic liver diseases that effectively restore the regenerative capacity of hepatocytes. The therapeutic concept is founded on research by Professor Lars Zender’s group at the University Hospital Tübingen, which identified mitogen-activated protein (MAP) kinase kinase 4 (MKK4) as a keyregulator of liver regeneration. Work by Professor Zender’s team showed that using small RNA molecules to suppress MKK4 gene expression restored the regenerative capacity of hepatocytes, even in severely diseased livers. Founded in 2015, HepaRegeniX is developing small-molecule MKK4 inhibitors to treat liver disorders, potentially including nonalcoholic steatohepatitis.
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
LeanSquare VC Fund · Liège, Liege, Belgium · 2 investments in the past 12 months
New Economy Startups Investor & Accelerator
Show more
Investment focus
  • Software, Music, Internet
  • Seed, Funding Round, Series A
  • Belgium, France, United States
Portfolio highlights
  • LinkByCar — Revolutionize fleet operations with LinkByCar. From real-time tracking to predictive maintenance, our advanced telematics solutions save time and reduce costs.
  • Bridge.audio — Bridge is for everyone working with music and audio. We provide private workspaces to manage, share, and connect better.
  • Base for music — Base for Music is the marketing solution specialized in fan acquisition, enabling you to achieve your growth goals and providing you with transparent da...
New Rhein VC Fund
New Rhein is a Philadelphia based healthcare venture capital firm focused on repurposed assets.
Show more
Investment focus
  • Medical, Biotechnology, Health Care
  • Series B, Series A, Seed
  • United States, Israel, Belgium
Portfolio highlights
  • Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
  • Corsair Pharma — Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.
  • Butterfly Medical — Butterfly, Butterfly Medical, BPH Treatment, BPH Office Procedure, Idan Geva, Minimally Invasive BPH, Prostate, Enlarged Prostate, Bening Prostate Hyperplasia, Urology
Quest for Growth VC Fund · Leuven, Vlaams-Brabant, Belgium
Quest for Growth (QGPLF) is an Internet company located in 19 Lei, Leuven, Flanders, Belgium.
Show more
Investment focus
  • Biotechnology, Hardware, Software
  • Funding Round, Series B, Series C
  • Belgium, France, The Netherlands
Portfolio highlights
  • Qpinch — Our patented QHT - Qpinch Heat Transformer - technology recovers and transforms waste heat into carbon neutral process heat.
  • Finquest — Tap into the largest private company database in the world to change the way you find and connect with M&A targets using Data, AI, & People.
  • Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
Limburg Startup VC Fund · Maastricht, Limburg, The Netherlands
Limburg Ventures is a venture capital fund that invests in startups in life sciences and related fields of advanced chemicals and materials.
Show more
Investment focus
  • Biotechnology, Life Science, Health Care
  • Funding Round, Series A, Series B
  • The Netherlands, France, Belgium
Portfolio highlights
  • FABPulous — FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, HealthInnovations, Limburg Ventures and NV Industriebank LIOF.The company has developed a technology that allows a simple, robust and ultra-rapid diluted plasma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.
  • Kriya Materials — Kriya Materials is the innovative developer and manufacturer of various metal oxide nano particles as well as their downstream dispersions and functional coating products thereof. Coatings play an important role in our everyday life, although often not recognized by those who do not master the art. Coatings are a big market and many products fallunder this category. Kriya Materials focuses itself on the development and manufacturing of various nano metal oxides which it uses internally for the development and production of very high end coatings.The coatings made by Kriya Materials are applied in a wide range of markets, some examples are the Plasma Panel and LCD industry, from Smartphone to touch panels to glass surfaces.
  • ReSolved Technologies — ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets.
Dental Innovation Alliance VC Fund · Raleigh, North Carolina, United States
Dental Innovation Alliance (DIA) is a venture capital company that invests in, advises on, and accelerates the growth of early-stage companies that are transforming dentistry through technology.
Show more
Investment focus
  • Software, Health Care, SaaS
  • Series A, Seed, Funding Round
  • Belgium, Germany, Switzerland
Portfolio highlights
  • Relu — Integrate Relu's automatic 3D segmentations seamlessly into your CBCT software.
  • Odne — Curing with light
  • Dentognostics GmbH — Dentognostics is a reasearch based firm that offers medicine and dentistry innovative and powerful systems for diagnostics, and therapy.
EQT Life Sciences VC Fund · Amsterdam, Noord-Holland, The Netherlands · 12 investments in the past 12 months
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland
Portfolio highlights
  • XyloCor Therapeutics — XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patientswith refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.
  • Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
  • Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
Earlybird Venture Capital VC Fund · Berlin, Berlin, Germany · 15 investments in the past 12 months
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Series A, Seed, Series B
  • Germany, United States, United Kingdom
Portfolio highlights
  • TopK — TopK features native support for both vector search and keyword search in a single, unified system. With its powerful query expression language, TopK enables you to build reliable search applications (semantic search, RAG, multi-modal, you name it) without juggling multiple databases or services. Our unified retrieval engine will evolve tosupport document transformation, query understanding (parse metadata filters from user query), and adaptive ranking (provide more relevant results by sending “relevance feedback” back to TopK) under one roof.
  • Arago — Arago is an AI and computer hardware company developing an energy-efficient AI chip powered by light, and its associated software.
  • Portal Biotech — Portal has created next generation solutions that address the significant opportunities in protein sequencing and metabolomics
Allegro Investment Fund VC Fund · Heverlee, Vlaams-Brabant, Belgium
Allegro Investment Fund is an open end seed capital investment fund, focussing on high-tech ventures. With a combined experience of more then 40 years of experience in high-tech start-up management, the AIF team adds smart money to your capital needs.
Show more
Investment focus
  • Software, Hardware, Apps
  • Funding Round, Series A, Series B
  • Belgium, United States, The Netherlands
Portfolio highlights
  • Visys — Visys NV, The optical sorting innovation Company, is a leading state-of-the-art provider of Digital automated sorting solutions to the global food and non-food processing industry.
  • Mass Relevance — Mass Relevance develops and offers cloud-based software for media and entertainment sectors.Its software enables social media content aggregation, filtration, and integration. The company's clientele includes December, 2010. The company was founded in 2009 and is based in Austin, Texas.In April 2014, Mass Relevance merged with Spredfast, forming a comprehensive social marketing company.
  • GreenPeak Technologies — GreenPeak Technologies operates as a fabless semiconductor and is one of the leaders in the ZigBee market with a rich offering of RF chips for the Smart Home and the IoT.Driven by the world’s MSOs, GreenPeak is proving its market leadership position as the Internet of Things connectivity technology provider for the Smart Home.GreenPeakTechnologies is a fabless semiconductor company and the leader in the ZigBee market with a rich offering of semiconductor products and software technologies for Smart Home data communications and the Internet of Things.The GreenPeak founders have significantly contributed to the invention of WiFi and made it into a commercial success, used by several billion people today. GreenPeak is recognised as a leader in developing new wireless technologies for consumer electronics, Smart Home applications and the IoT/IoE, demonstrating rapid growth and adoption by major customers around the globe.It offers its products for original equipment manufacturers in the United States, Europe, and Asia. The company was formerly known as Xanadu Wireless and changed its name to GreenPeak Technologies B.V. in 2007. GreenPeak Technologies was founded in 2004 and is based in Utrecht, the Netherlands with additional offices in Belgium, Japan, France, California, US as well as in Korea and Hong Kong.
Ackermans & van Haaren VC Fund · Antwerpen, Antwerpen, Belgium
Ackermans & van Haaren is a diversified group active in 5 segments: Marine Engineering & Infrastructure; Private Banking; Real Estate, Leisure & Senior Care; Energy & Resources; Development Capital. Marine Engineering & Infrastructure: DEME, one of the largest dredging companies in the world - Algemene Aannemingen Van Laere,a leading contractor in Belgium. Ackermans & van Haaren is an independent and diversified group aiming at creating shareholder value through long-term investments in a limited number of companies with growth potential on an international level.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • Belgium, India
Portfolio highlights
  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Medikabazaar — Medikabazaar is an online B2B marketspace for medical supplies and equipment. They are a single point of contact for all product-based needs, enabling medical institutions and individual practitioners alike to cut down on operational costs and making the best global brands available locally, all aided with the miracle that goes by the name oftechnology. They are connected with more than 50,000 medical establishments, 1,50,000 Independent Practitioners, and have partnered with 13,000+ suppliers all over India including ones in Tier 2, Tier 3 cities, and remoter locations to establish a strong foothold in India and simultaneously earn the respect of our clients. With the power of technology, we organized a haywire market in a country with perhaps the largest and most complex geographical structure in the world for this purpose. Our last-mile delivery system and 26 strategically placed Fulfilment Centres across India enable us to deliver essential medical supplies to healthcare facilities and help them nurture quality and timely patient care. With our first international office in the Middle East, we are transcending boundaries to deliver care, everywhere.
  • Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
Financière Spin-Off Luxembourgeoise VC Fund
Specializes in spin-off and spin-out investments.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A
  • Belgium
Portfolio highlights
  • Synergia Medical — Synergia Medical aims at developing and commercializing next generation neurostimulation devices. It relies on a seasoned management team with extensive experience in developing implantable neurostimulators.In only three years time, the company became ISO13485 certified, created and sold an OEM external neurostimulator for a motorized amputeeprosthesis arm and developed its first version of the NAOS platform.Supported by private investors and public research grants, the company has quickly grown to a team of thirteen highly skilled multidisciplinary professionals.
The CoFoundry VC Fund · Antwerp, Antwerpen, Belgium
The CoFoundry helps entrepreneurs transform their ideas into sustainable companies. Some say we cut through the funding hype and work hard to give your business a sustainable future.
Show more
Investment focus
  • Software, Network Security, SaaS
  • Seed, Series A, Funding Round
  • Belgium, The Netherlands, United States
Portfolio highlights
  • Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
  • MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
  • Vaultspeed — Save your teams months of headache with a no-code approach to automate your multi-source data integration, Data Vault modeling & ETL/DDL code generation.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 20 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Investsud VC Fund · Marche-en-famenne, Luxembourg, Belgium
Investsud is a capital firm that works on investments in different industries including food, general industry, and technological startup.
Show more
Investment focus
  • Biotechnology, Medical, SaaS
  • Series A, Seed, Series B
  • Belgium, France
Portfolio highlights
  • TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
  • Brenus Pharma — Unlocking the full potential of immuno-oncology by generating first-in-class immunotherapies to initiate a multi-specific in vivo immune response against tumors
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
SFPI-FPIM VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium
The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Funding Round, Series B, Series A
  • Belgium, United States, France
Portfolio highlights
  • Cohabs — We create sustainable & community-driven shared homes around the world for young workers and interns. Join our community.
  • Univercells — We are biotech innovators, rooted in Belgium, driven by one purpose: To transform how biotech drugs are made so everyone, everywhere, can get them.
  • Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
CPH Banque VC Fund · Tournai, Basse-Normandie, France
CPH Banque is a financial services company that provides loan, head full projects and mobile banking services.
Show more
Investment focus
  • Health Care, Medical, Training
  • Funding Round, Series B, Series C
  • Belgium
Portfolio highlights
  • OncoDNA — OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.
  • I-care Group — Achieve unprecedented asset reliability and performance with I-care patented monitoring IoT, AI-driven insights, and worldwide expertise.
  • Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
Delta Partners VC Fund · Leopardstown, Dublin, Ireland
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Imvizar — Transform your buildings, office spaces, visitor attractions, and parks with an immersive and visual storytelling experience using augmented reality. Discover unique ways to tell your story at Imvizar.
  • ZeroMission — ZeroMission is an electromobility and lead innovator in software development, and power-energy infrastructure.ZeroMission offers fleet management software to businesses that own and operate fleets of commercial electric vehicles (EVs).
  • MarketSizer — MarketSizer offers subscription-based competitive intelligence and market insights for SaaS vendors who want to strategically grow their business.
HTGF (High-Tech Gruenderfonds) VC Fund · Bonn, Nordrhein-Westfalen, Germany · 45 investments in the past 12 months
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • Mevaldi — Mevaldi is a biotechnology company. They investigate, select, and bring to market new technologies in the field of bio-based chemicals. They provide a revolutionary approach that integrates the large-scale biological conversion of sugars to low-cost mevalonolactone with a further cascade of thermo-catalytic conversions to various bio-monomers.
  • TrustNXT — TrustNXT is the trust authority for digital media, providing innovative software solutions to safeguard digital photos and videos from manipulation. Our technology verifies the origin, content, and metadata of digital media, while advanced forensic tools empower users to assess the trustworthiness of visual content. With a mission to protectauthenticity and foster safer digital environments, TrustNXT is committed to combating fraud and ensuring the integrity of digital media in today's digital world.
  • Pactos — Pactos streamlines and digitizes processes to enable large and medium-sized businesses to effectively and centrally procure and manage their contingent labor.
Gimv VC Fund · Antwerpen, Antwerpen, Belgium
Gimv, a trusted European investment company, helps mid-market businesses create sustainable value through growth capital and expertise across diverse sectors.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Funding Round, Private Equity
  • Belgium, United States, France
Portfolio highlights
  • Curana — Curana is a manufacturer of bike equipment and accessories.
  • Kivu Bioscience — At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer treatments.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Belgium by industry